Empagliflozin vs Sacubitril-Valsartan

Empagliflozin vs Sacubitril-Valsartan: Overview

This comparison examines the pharmacological differences between Empagliflozin and Sacubitril-Valsartan.

Mechanism of Action

Empagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption.

Sacubitril-Valsartan: Angiotensin receptor-neprilysin inhibitor (ARNI) combining neprilysin inhibition with AT1 receptor blockade.

Pharmacokinetics

Half-life: Empagliflozin — 12.4 hours; Sacubitril-Valsartan — 11.5 hours.

Chemical Properties

Molecular Formula: Empagliflozin — C23H27ClO7; Sacubitril-Valsartan — C24H29N2O5.

Molecular Weight: Empagliflozin — 450.9100 g/mol; Sacubitril-Valsartan — 414.5010 g/mol.

Type: Empagliflozin — Small molecule; Sacubitril-Valsartan — Small molecule.